Skip to main content

Nasdaq Markets

How We Could Be Sabotaging Ourselves

6 years ago
In this episode of Rule Breaker Investing, Motley Fool co-founder David Gardner interviews Shirzad Chamine, the author of The New York Times best-selling book Positive Intelligence. The judge, controller, avoider, victim, restless one . . . these are some of the inner saboteurs w

Why CBRE Group Stock Is Jumping Today

6 years ago
What happenedShares of CBRE Group (NYSE: CBRE) have jumped today, up by 12% as of 1:15 p.m. EDT, after the company reported third-quarter earnings results. CBRE also said it was moving its headquarters from Los Angeles to Dallas, confirming recent rumors.

Here's Why SunOpta Stock Fell on Thursday

6 years ago
What happenedShares of global food company SunOpta (NASDAQ: STKL) were going down on Thursday after it reported results for the third quarter of 2020. The company's revenue and profit were slightly ahead of expectations, and management was upbeat about its performance thus far in

Why 8x8 Stock Is Soaring Today

6 years ago
What happenedShares of 8x8 (NYSE: EGHT) are soaring today, up by 12% as of 12:40 p.m. EDT, after the company reported fiscal second-quarter earnings. The results topped consensus estimates, although guidance came in below expectations.

Seven-Year Note Auction Attracts Below Average Demand

6 years ago
(RTTNews) - The Treasury Department finished off this week's series of announcements of the results of its long-term securities auctions on Thursday, revealing that its sale of $53 billion worth of seven-year notes attracted below average demand.The seven-year note auction drew a

FanDuel Scores a Big Sports Betting Win in Atlantic City

6 years ago
FanDuel continues to be the sports betting champion in New Jersey after the state posted another record-breaking month in September. Now the sports betting company intends to open an in-person sportsbook at Bally's in Atlantic City after Caesars Entertainment completes the sale o

Why Investors Loved Moderna's Q3 Results

6 years ago
Moderna's (NASDAQ: MRNA) primary focus right now is to hopefully win regulatory approvals or authorizations for coronavirus vaccine mRNA-1273 to make it to the market. In the meantime, though, the biotech also has a business to run.That business was front and center when Moderna
Checked
24 minutes 37 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed